Clinical trial
A Multicenter, Prospective, Non-interventional Observational Study to Investigate the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia
NCT05120895 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Non-interventional Observational Study to Investigate the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia
- Lead sponsor
- Daiichi Sankyo
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 10, 2021
- Completion date
- December 27, 2024
- Enrollment
- 3,060 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia